The Michigan Alzheimer’s Disease Center (MADC) is located at
2101 Commonwealth Blvd., Suite D
Ann Arbor, MI 48105.
For general questions about the MADC, please call
Frequently Asked Questions
If I have concerns about my memory or my family member’s memory, who should I contact for more information?
If you or a family member is concerned about memory changes, please talk to your primary care physician (PCP). Your PCP may refer you to a specialist, such as a neurologist or geriatric physician for further evaluation. The Cognitive Disorders Program is a specialty clinic within the University of Michigan Department of Neurology that offers a complete evaluation for people with memory problems and provides ongoing care. For more information or to schedule an appointment, call
Where is the MADC located and who should I contact for specific directions and more information about parking?
The MADC is located at 2101 Commonwealth Blvd., Suite D, Ann Arbor MI 48105. Parking is on-site and free. For further information, please call
If you are over the age of 55, with or without memory concerns, we encourage you to fill out a Research Volunteer Form. With your permission, a team of professionals may review your medical records to determine your eligibility. Most of our studies require you to bring a study partner (e.g., family member, neighbor, or friend) to your research appointments. For further information, please contact our study coordinator, Stephen Campbell at
The MADC is currently enrolling for brain imaging and observational studies. The brain imaging studies (PET scans, MRI, EEG) explore the sensitivity and accuracy of a particular imaging technique in the early detection of disease or in measuring brain changes over time. Observational studies measure naturally-occurring changes in health behavior and health status over time. The purpose of these MADC studies is to increase our understanding about the cause of and treatments for diseases that impair memory. Each study protocol varies in procedures and time commitment. For further information about our currently enrolling studies, please contact our study coordinator, Stephen Campbell at
Anyone who participates in our University of Michigan Memory and Aging Project (UM-MAP) can choose to give a blood sample to assess for Apolipoprotein (ApoE) gene type. This testing is done for research purposes only – the results will be kept confidential and will not be provided to study participants.
If you are interested in participating in any MADC-supported study, please complete the Research Volunteer Form and mail it to our study coordinator, Stephen Campbell, at 2101 Commonwealth Blvd, Suite D, Ann Arbor, MI 49105. Please call
Results from memory testing and/or brain imaging can be shared with your doctor if you complete a Release of Information form, which will be provided by the study coordinator. All tests are performed for research purposes only, but some tests may have relevance to your clinical care. Blood samples obtained for genetic testing are destroyed and results are not released to study participants.
Autopsy is an important part of both clinical care of and research into Alzheimer disease and related disorders. Specific clinical diagnosis of dementing disorders, even when assigned by expert clinicians, is relatively inaccurate. Precise diagnosis is possible only with neuropathologic examination after death. Providing families with a complete understanding of the disease affecting their loved one requires autopsy evaluation. Autopsy evaluations are also crucial learning experiences for treating physicians, particularly in unusual clinical disorders, and play a major role in improving medical care.
Autopsy is essential for research progress in Alzheimer disease and related disorders. Much of our current understanding of the disease processes in Alzheimer disease and related disorders comes from autopsy studies. Looking ahead, autopsy studies will be essential for developing more accurate, non-invasive methods for investigating dementias. Many important studies investigating the basic nature of the disease processes causing nerve cell death in Alzheimer disease and related disorders can only be performed with human autopsy tissues.
Brain autopsy services are offered to participants enrolled in the University of Michigan Memory and Aging Project (UM-MAP), our largest and longest running observational study. A separate consent for brain autopsy is obtained once enrolled in this study.
The MADC is committed to helping patients, families and professionals connect to memory and aging programs and services. If you have questions please call